To include your compound in the COVID-19 Resource Center, submit it here.

Microbiome companies Finch and Crestovo merge

Microbiome companies Crestovo LLC (Cambridge, Mass.) and Finch Therapeutics Inc. (Somerville, Mass.) merged to form Finch Therapeutics Group (Somerville, Mass.), which will focus on developing oral alternatives to fecal microbiota transplant.

Crestovo's lead candidate, CP101, is

Read the full 355 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE